JAK2V617F mutation in patients with beta-thalassemia disease: prevalence and clinical characteristics. Teawtrakul N, Chansai S, Yamsri S, Ungarreevittaya P, et al. Ann Hematol 2021;100:2863-2865.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Teawtrakul N, Chansai S, Yamsri S, Ungarreevittaya P, et al. JAK2V617F mutation in patients with beta-thalassemia disease: prevalence and clinical characteristics. Ann Hematol 2021;100:2863-2865.
PMID: 34181056